Company intelligence / Profile preview

Bellus Aesthetics

Dallas, Texas, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Crown Aesthetics, formerly known as Bellus Medical, is a leading medical aesthetics company focused on providing innovative skin rejuvenation solutions to physician-directed practices. The company is best known for developing SkinPen, the first FDA-cleared microneedling device, which is used to treat acne scars and neck wrinkles. In addition to its flagship device, the company offers a portfolio of products including the Skinfuse post-microneedling protocol and the ProGen PRP Advantage system. Following its acquisition by Crown Laboratories in 2018, the company has expanded its global footprint and continues to lead in the minimally invasive aesthetics market.

Therapeutic areas: Dermatology
Modalities: DeviceTopical
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Bellus Aesthetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bellus Aesthetics.

Explore the full profile